CClinicalTrials.gg
Status unknownNCT03531424AR-PCIUpdated May 22, 2018

Augmented-Reality CTA Plus Angiography vs Angiography Alone for Guiding PCI in Coronary Lesions - Randomized Study

An interventional study of Angiographic guided PCI and Augmented-Reality CTA guided PCI in Coronary Artery Disease, sponsored by Paul Knaapen. Status unknown at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-05-22.

Sponsored by Paul Knaapen · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to compare revascularization strategy and its immediate results after augmented-reality computed tomography angiography (CTA) guided vs. standard angiography guided percutaneous coronary intervention (PCI) in native coronary lesions.

Read the detailed description

While stand-alone angiography is the first-line imaging modality for guidance of PCI, it has some inherent limitations which may result in suboptimal stent placement related to residual reference segment disease and stent underexpansion. Coronary CTA, on the other hand, can provide reliable measurements of the vessel size and lesion length as well as the visualization of the morphological features of coronary plaque, and has been suggested as potentially valuable for changing PCI technique. The AR-PCI trial has been designed as a single-center, investigator initiated and investigator sponsored, randomized (1:1), controlled, prospective clinical trial. It is hypothesized that the review of CTA datasets using augmented-reality glass in the catheterization laboratory could influence PCI treatment strategy and its immediate results by more adequate lesion coverage with less residual disease and better stent expansion as compared to traditional angiography-guided PCI alone.

02

Conditions studied

  • Coronary Artery Disease

Keywords

  • Coronary Stenosis
  • Percutaneous Coronary Intervention
  • Stents
  • Computed Tomography Angiography
  • Augmented Reality
03

In context

Coronary Artery Disease

5,598 studies on the registry are indexed under Coronary Artery Disease; 957 are open to participants now.

This study's planned enrollment of 60 is below the median of 124 across 3,436 interventional studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

This is the only study on the registry with Paul Knaapen as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • patients with documented obstructive CAD defined as the presence of at least 1 stenosis ≥70% in a native coronary artery in whom PCI is considered based on clinical grounds

Exclusion criteria

Exclusion Criteria:

  • refusal or inability to provide written informed consent
  • subjects in whom the quality of coronary CTA is insufficient
  • bifurcation lesions, by which strategies other than a single cross-over stent technique are anticipated
  • left main coronary artery stenosis
  • chronic total occlusion
  • in-stent restenosis
  • chronic renal failure (estimated glomerular filtration rate \<30 ml/min)
  • known allergy to contrast
  • untreated hyperthyroidism
  • pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Angiographic guided PCI

    Angiographic guided PCI is coronary revascularization based on stand-alone angiography.

    Procedure: Angiographic guided PCI

  • Experimental
    CTA guided PCI

    CTA guided PCI is coronary revascularization based on systematic use of CTA plus coronary angiography.

    Procedure: Augmented-Reality CTA guided PCI

Interventions

  • ProcedureAngiographic guided PCI

    Angiographic guided PCI is coronary revascularization based on stand-alone angiography.

  • ProcedureAugmented-Reality CTA guided PCI

    Augmented-Reality CTA guided PCI is coronary revascularization based on systematic use of CTA datasets displayed in augmented-reality glass plus coronary angiography.

06

What researchers measure

Primary outcomes

  1. Stent length

    Length of the stented segment

    Time frame: 1 day

  2. Predicted stent diameter

    Predicted final stent diameter according to a compliance chart

    Time frame: 1 day

Secondary outcomes

  1. Nominal stent diameter

    Nominal diameter of the implanted stent

    Time frame: 1 day

  2. Number of stents

    Total number of stents

    Time frame: 1 day

  3. Predilation

    Balloon predilation for lesion modification

    Time frame: 1 day

  4. Postdilation

    Balloon postdilation for stent expansion

    Time frame: 1 day

  5. Maximal balloon pressure

    Maximal balloon pressure applied during PCI

    Time frame: 1 day

  6. Maximal balloon diameter

    Maximal balloon diameter applied during PCI

    Time frame: 1 day

  7. Stent-edge dissection

    Stent-edge dissection by coronary angiography

    Time frame: 1 day

  8. Post-procedural residual diameter stenosis

    Post-procedural residual diameter stenosis by 3D QCA

    Time frame: 1 day

  9. Post-procedural residual area stenosis

    Post-procedural residual area stenosis by 3D QCA

    Time frame: 1 day

  10. Post-procedural minimum lumen diameter

    Post-procedural minimum lumen diameter by 3D QCA

    Time frame: 1 day

  11. Post-procedural minimum lumen area

    Post-procedural minimum lumen area by 3D QCA

    Time frame: 1 day

  12. Post-procedural lumen diameters at the reference segments

    Post-procedural lumen diameters at the reference segments by 3D QCA

    Time frame: 1 day

  13. Post-procedural lumen areas at the reference segments

    Post-procedural lumen areas at the reference segments by 3D QCA

    Time frame: 1 day

  14. Post-procedural volume of the stented segment

    Post-procedural volume of the stented segment by 3D QCA

    Time frame: 1 day

  15. Post-procedural volume of the reference segments

    Post-procedural volume of the reference segments by 3D QCA

    Time frame: 1 day

07

Study locations

1 of 1 sites recruiting
  • VU University Medical Center Amsterdam
    Amsterdam, De Boelelaan 1117 1081 HV, Netherlands
    • Maksymilian P. Opolski, MD, PhD · Contact · m.opolski@vumc.nl · +48501444303
    • Maksymilian P. Opolski, MD, PhD · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03531424
Lead sponsor
Paul Knaapen
Responsible party
Paul Knaapen (Clinical Professor, Amsterdam UMC, location VUmc) — Sponsor-investigator
First posted
May 21, 2018
Start date
Apr 25, 2018
Primary completion
Sep 2018 (estimated)
Completion
Dec 2018 (estimated)
Last update
May 22, 2018

Study contacts

Maksymilian P. Opolski, MD, PhD
Contact
m.opolski@vumc.nl
+48501444303

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion